DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway
Cancer Cell International,
Abstract Background Disabled homolog 2 interacting protein (DAB2IP) plays a tumor-suppressive role in several types of human…